New

Chrome Plugin Live! Redefine the way you read FinTwit 🚀 Install Now

You have successfully sign out
Loading...
Shape
NEXGEL, Inc.
NXGL
Shape
US Flag

NASDAQ

Unprofitable

Unprofitable

27M

Medical - Instruments & Supplies

Next Earning date - 14 Nov 2024

27M

Medical - Instruments & Supplies

Next Earning date - 14 Nov 2024

2.99USD
Shape0.09 ( 3.10%)
favorite-chart

Relative Strenght

23
favorite-chart

Volume Buzz

-10%
favorite-chart

Earning Acce

No
favorite-chart

Dist 52w H.

8%

Quote Panel

Shape
Updated October 26, 2024
1W -3.24 % 1M 15.44 % 3M 0.00 % 1Y 86.88 %

Key Metrics

Shape
  • Market Cap

    26.64M


  • Shares Outstanding

    8.91M


  • Share in Float

    6.94M


  • Dividende

    0


  • Earning Date

    14 Nov 2024


  • Price Target

    2.99


  • Average Volume

    51360


  • Beta

    0.754


  • Range

    1.51-3.24


  • Industry

    Medical - Instruments & Supplies


  • Website

    https://nexgel.com


  • Sector

    Healthcare


Fundamentals

Shape

N/A

P/E Ratio

5.31x

P/S Ratio

4.48x

P/B Ratio

0.2

Debt/Equity

-67.6%

Net Margin

$-0.6

EPS

How NXGL compares to sector?

P/E Ratio

Relative Strength

Shape

NXGL

Sector

loading...

Top 5 RS in Group

Symbol

Company

RS

5-Day Perf.

Forecast

Shape

$12M

Shape748%

2025-Revenue

$0.04

Shape129%

2025-EPS

$12M

Shape-1097%

2025-EBITDA

Analyst rating

No Data Available

Last analyst upgrade/downgrade

Maxim Group

initialise

Previous: Not converted

2022-02-25

Now: Buy

Earnings GrowthShape

status-upYoY

Current

Estimates

Q3.22

arrow
arrow

N/A

-0.22
vs -0.23

Q4.22

arrow
arrow

N/A

-0.11
vs -0.29

Q1.23

arrow
arrow

N/A

-0.15
vs -0.33

Q2.23

arrow
arrow

N/A

-0.12
vs -0.19

Q3.23

arrow
arrow

N/A

-0.10
vs -0.22

Q4.23

arrow
arrow

N/A

-0.19
vs -0.11

Q1.24

arrow
arrow

N/A

-0.14
vs -0.15

Q2.24

arrow
arrow

N/A

-0.14
vs -0.12

Q3.24

arrow
arrow

N/A

-0.10
vs -0.10

Q4.24

arrow
arrow

N/A

-0.10
vs -0.19

Sales GrowthShape

status-upYoY

Current

Estimates

Q3.22

arrow
arrow

+70%

568K  vs 335K

Q4.22

arrow
arrow

-2%

524K  vs 533K

Q1.23

arrow
arrow

+57%

620K  vs 396K

Q2.23

arrow
arrow

+108%

1.2M  vs 561K

Q3.23

arrow
arrow

+115%

1.2M  vs 568K

Q4.23

arrow
arrow

+106%

1.1M  vs 524K

Q1.24

arrow
arrow

+104%

1.3M  vs 620K

Q2.24

arrow
arrow

+23%

1.4M  vs 1.2M

Q3.24

arrow
arrow

+133%

2.8M  vs 1.2M

Q4.24

arrow
arrow

+176%

3M  vs 1.1M

Return on EquityShape

status-upQoQ

Q3.22

arrow
arrow

-17%

-0.17
vs -0.14

Q4.22

arrow
arrow

-7%

-0.07
vs -0.17

Q1.23

arrow
arrow

-12%

-0.12
vs -0.07

Q2.23

arrow
arrow

-11%

-0.11
vs -0.12

Q3.23

arrow
arrow

-10%

-0.10
vs -0.11

Q4.23

arrow
arrow

-23%

-0.23
vs -0.10

Q1.24

arrow
arrow

-18%

-0.18
vs -0.23

Q2.24

arrow
arrow

-21%

-0.21
vs -0.18

Institutionnal OwnershipShape

status-upQoQ

Q3.22

arrow
arrow

7

7
vs 7

NA

Q4.22

arrow
arrow

8

8
vs 7

14%

Q1.23

arrow
arrow

8

8
vs 8

NA

Q2.23

arrow
arrow

11

11
vs 8

38%

Q3.23

arrow
arrow

9

9
vs 11

-18%

Q4.23

arrow
arrow

9

9
vs 9

NA

Q1.24

arrow
arrow

12

12
vs 9

33%

Q2.24

arrow
arrow

11

11
vs 12

-8%

Earnings Growth

Latest News